KIR3DL2 contributes to the typing of acute-type adult T-cell leukemia and is a potential therapeutic target. Cheminant M, Lhermitte L, Bruneau J, Sicard H, et al. Blood 2022 Jun 10. pii: 485527. doi: 10.1182/blood.2022016765.

Read + Share

Amedeo Smart

Independent Medical Education

Cheminant M, Lhermitte L, Bruneau J, Sicard H, et al. KIR3DL2 contributes to the typing of acute-type adult T-cell leukemia and is a potential therapeutic target. Blood 2022 Jun 10. pii: 485527. doi: 10.1182/blood.2022016765.
PMID: 35687761